share_log

東陽光長江藥業：聯合公告 根據收購守則規則第3.7條就本公司的可能合併作出的每月更新

HEC CJ PHARM: JOINT ANNOUNCEMENT MONTHLY UPDATE PURSUANT TO RULE 3.7 OF THE TAKEOVERS CODE IN RELATION TO THE POSSIBLE MERGER OF THE COMPANY

香港交易所 ·  Apr 8 05:34
Summary by Moomoo AI
宜昌東陽光長江藥業股份有限公司（「本公司」）與廣東東陽光藥業股份有限公司（「潛在要約人」）於2024年4月8日發布聯合公告，更新有關潛在要約人可能透過換股方式吸收合併本公司的進展。根據香港證監會《公司收購及合併守則》規則3.7，潛在要約人已獲執行人員授予兩項寬免：一是免除強制性全面要約責任，二是免卻就可能合併支付現金或提供現金選擇的責任。目前，潛在要約人尚未提出明確的合併方案，合併的結構、條款及其他詳情仍未確定，且合併是否進行存在不確定性。本公司將按收購守則每月更新可能合併進度，直至作出最終決定。股東及潛在投資者被提醒在交易股份時需審慎行事。
宜昌東陽光長江藥業股份有限公司（「本公司」）與廣東東陽光藥業股份有限公司（「潛在要約人」）於2024年4月8日發布聯合公告，更新有關潛在要約人可能透過換股方式吸收合併本公司的進展。根據香港證監會《公司收購及合併守則》規則3.7，潛在要約人已獲執行人員授予兩項寬免：一是免除強制性全面要約責任，二是免卻就可能合併支付現金或提供現金選擇的責任。目前，潛在要約人尚未提出明確的合併方案，合併的結構、條款及其他詳情仍未確定，且合併是否進行存在不確定性。本公司將按收購守則每月更新可能合併進度，直至作出最終決定。股東及潛在投資者被提醒在交易股份時需審慎行事。
Yichang East Sunlight Changjiang Pharmaceutical Co., Ltd. (the “Company”) and Guangdong Sunlight Pharmaceutical Co., Ltd. (the “Prospective Bidder”) issued a joint announcement on 8 April 2024 updating the progress of the Company regarding potential bidders who may absorb the merger through the exchange method. Pursuant to Rule 3.7 of the Hong Kong Securities and Exchange Code of Companies, potential bidders have been granted two waivers to the executors: one exemption from compulsory comprehensive contractual liability, and the other from the obligation to pay cash or provide cash options in respect of a possible merger. At present, the potential Contractors have not yet proposed a clear plan for the merger, the structure, terms and other details of the merger remain uncertain, and there is uncertainty as to whether the merger will take place. The Company will update monthly and consolidate possible progress in accordance with the Acquisition Code until a final decision is made. Shareholders and potential investors are reminded to exercise caution when trading shares.
Yichang East Sunlight Changjiang Pharmaceutical Co., Ltd. (the “Company”) and Guangdong Sunlight Pharmaceutical Co., Ltd. (the “Prospective Bidder”) issued a joint announcement on 8 April 2024 updating the progress of the Company regarding potential bidders who may absorb the merger through the exchange method. Pursuant to Rule 3.7 of the Hong Kong Securities and Exchange Code of Companies, potential bidders have been granted two waivers to the executors: one exemption from compulsory comprehensive contractual liability, and the other from the obligation to pay cash or provide cash options in respect of a possible merger. At present, the potential Contractors have not yet proposed a clear plan for the merger, the structure, terms and other details of the merger remain uncertain, and there is uncertainty as to whether the merger will take place. The Company will update monthly and consolidate possible progress in accordance with the Acquisition Code until a final decision is made. Shareholders and potential investors are reminded to exercise caution when trading shares.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1     View Translation

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more